COMMUNIQUÉS West-GlobeNewswire

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 15:15

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 22nd Annual Global [...]

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 15:14

REYKJAVIK, Iceland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its [...]

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024

26/08/2024 - 15:10

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]

Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference

26/08/2024 - 15:00

YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]

Positron Corporation Announces Sale of NeuSight PET-CT Scanner

26/08/2024 - 15:00

Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11

26/08/2024 - 15:00

TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]

Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amyotrophic Lateral Sclerosis (ALS)

26/08/2024 - 15:00

Grant to support the in vivo development of first-in-class condensate-modifying drugs (c-mods) targeting the TDP-43 condensatopathy in ALS BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. , the [...]

EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community

26/08/2024 - 15:00

SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- EverythingALS is proud to announce the launch of its new mobile app, now available on both the iOS and Android marketplaces. This app represents a significant upgrade from the [...]

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

26/08/2024 - 14:30

PASADENA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), today announced the dosing of the first patient in a new clinical trial in [...]

Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old

26/08/2024 - 14:02

-- Label expansion sought to treat younger children with Bardet-Biedl syndrome or POMC/LEPR deficiency -- -- FDA sets PDUFA goal date of December 26, 2024 -- BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Rhythm [...]

CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism

26/08/2024 - 14:00

CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn ® Brands will exhibit at the 46 th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on [...]

Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Respiratory Society International Congress 2024

26/08/2024 - 14:00

CAMBRIDGE, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, [...]

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

26/08/2024 - 14:00

SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will participate in the H.C. Wainwright [...]

Halberd Corp. Issues Letter to Shareholders

26/08/2024 - 14:00

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it shareholders: Halberd Corp. - Taking a Moment to Recenter Our Technical Progress [...]

Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow

26/08/2024 - 14:00

DURHAM, N.C., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), today released a [...]

Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September

26/08/2024 - 14:00

BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]

CarnoSyn® Brands présente TriBsyn™ au 46e congrès de l’ESPEN sur la nutrition clinique et le métabolisme

26/08/2024 - 14:00

CARLSBAD, Californie, 26 août 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) et CarnoSyn ® Brands seront présentes au 46 e Congrès de l’ESPEN sur la nutrition clinique et le métabolisme qui se [...]

Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 14:00

CONSHOHOCKEN, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Morgan Stanley 22 nd Annual Global Healthcare Conference on [...]

Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

26/08/2024 - 14:00

MONTREAL and CHARLOTTE, N.C., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]